A new review explores how pregnancy hormones affect maternal bone health, potentially leading to a rare condition called Pregnancy and Lactation-Associated Osteoporosis (PLO). During pregnancy, the mother's endocrine system undergoes major changes, and the placenta contributes to bone remodeling. The review focuses on how these hormonal shifts influence osteoclasts and osteoblasts, the cells that break down and build bone.
The study is a mini review, meaning it summarizes existing research rather than presenting new data. It did not include a specific number of participants or a controlled comparison. The authors note that data on interactions between certain hormones and skeletal cells remain limited.
No safety concerns or adverse events were reported in this review. Because it is a summary of existing knowledge, it does not provide new evidence about treatment or prevention.
For pregnant women, this review highlights that hormonal changes are a normal part of pregnancy, but in rare cases they may contribute to bone loss. Anyone concerned about bone health during pregnancy should discuss it with their healthcare provider.
